Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
49.8M
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
44.4M
-
Shares change
-
-98.6K
-
Total reported value, excl. options
-
$1.84B
-
Value change
-
-$9.01M
-
Put/Call ratio
-
0
-
Number of buys
-
129
-
Number of sells
-
-75
-
Price
-
$41.45
Significant Holders of AtriCure, Inc. - Common Shares (ATRC) as of Q1 2023
243 filings reported holding ATRC - AtriCure, Inc. - Common Shares as of Q1 2023.
AtriCure, Inc. - Common Shares (ATRC) has 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.4M shares
of 49.8M outstanding shares and own 89.28% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.53M shares), BlackRock Inc. (3.86M shares), ALLIANCEBERNSTEIN L.P. (3.12M shares), Champlain Investment Partners, LLC (1.89M shares), FRED ALGER MANAGEMENT, LLC (1.51M shares), WELLINGTON MANAGEMENT GROUP LLP (1.48M shares), First Light Asset Management, LLC (1.46M shares), Invesco Ltd. (1.42M shares), MACQUARIE GROUP LTD (1.41M shares), and MILLENNIUM MANAGEMENT LLC (1.19M shares).
This table shows the top 217 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.